" class="no-js "lang="en-US"> Rutul R. Shah - Medtech Alert
Friday, March 29, 2024
Rutul R. Shah

Rutul R. Shah

About Rutul R. Shah

Mr. Shah brings to the role more than 17 years of exNames Rutul R. Shah Chief Operating Officerperience in the biopharmaceutical industry, of which 8 years have been focused exclusively on innovations in gene and cell therapies. Mr. Shah has broad leadership experience and expertise in alliance management, portfolio management, program and project management, and operations. Prior to joining Precigen, Mr. Shah spent a decade in scientific positions focused on the development of protein and antibody drugs at Zyngenia, Teva Biopharmaceuticals USA, CoGenesys, and Human Genome Sciences. Mr. Shah graduated with a BE degree in Chemical Engineering from Gujarat University in India and MS degree in Bioengineering from the University of Illinois, Chicago.

Related Story

Precigen Names Rutul R. Shah Chief Operating Officer

September 22 2022

Precigen, Inc. ( Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies […]